Bektur, CNurgozhin, TAbdukhakimova, D2017-12-132017-12-132015-11-01C Bektur, T Nurgozhin, D Abdukhakimova, PGI28 - Cost-Effectiveness of Simeprevir Vs. Telaprevir for The Triple Therapy of Hepatitis C In Kazakhstan, In Value in Health, Volume 18, Issue 7, 2015, Page A62710983015https://www.sciencedirect.com/science/article/pii/S1098301515042850http://nur.nu.edu.kz/handle/123456789/2861Hepatitis C Virus(HCV) is a growing health problem in the world. The aim of this study is to estimate a cost-effectiveness of a triple therapy(TT) with simeprevir compared to a TT with telaprevir for the previously treated with double therapy HCV patients in Kazakhstan.enOpen Access - the content is available to the general publicArticleCopyright © 2015 Published by Elsevier Inc.